Introduction: Breast tuberculosis is a disease that is difficult to diagnose with its clinical appearance and can be confused with breast abscesses and breast carcinomas. In this study, we aimed to analyze 24 patients diagnosed with breast tuberculosis, followed up and treated.
Material and Method: Among 4489 patients examined in the breast diseases outpatient clinic between January 2012 and December 2020, patients diagnosed with breast tuberculosis were evaluated retrospectively. Demographic, clinical features, radiological findings, histopathological and microbiological findings of the patients were recorded. Diagnosis, treatment protocols and treatment outcomes were evaluated.
Results: A total of 24 breast tuberculosis cases were analyzed in the study. The mean age was 41.6 (28-64 years) and all patients were diagnosed for the first time. There was a history of oral contraceptive use in 10 patients. Among patients, 19 of them were in the reproductive age, and five patients were in the postmenopausal period. Four patients were in lactating period. On physical examination, breast mass was detected in 16 (67%) patients, abscess was present in 5 patients (20.8%), and sinus and discharge were evident in three patients (12.5%). Breast ultrasonography revealed a breast mass in 16 patients (67%), abscess in eight patients (33%), and axillary lymphadenopathy in six patients (25%). The diagnosis was made by core biopsy in 10 (41.6%) patients, fine-needle aspiration biopsy in three patients (12.5%), and incisional biopsy in 11 patients (45.8%). All patients were given quadruple antituberculosis therapy in the first 2 months for 9 months, and double antituberculosis therapy for 7 months. In addition to antituberculosis treatment, mass excision was performed in three patients (12.5%), segmental mastectomy in one patient (4.1%), simple mastectomy in one patient (4.1%), and abscess drainage were completed in eight patients (33.3%). Cure was achieved in all patients after treatment.
Conclusion: Breast tuberculosis is a rare disease that can be difficult to diagnose unless the disease itself is suspected. As the diagnosis of the disease is delayed, the disease becomes complicated and the need for surgical treatment increases as well as medical treatment. Although there are different opinions about the duration of the treatment, in our study, cure was achieved with 9 months of treatment and no recurrence was observed in the 1-year follow-up. Since 10 patients had a history of oral contraceptive use, further research is needed to understand whether oral contraceptive use is a predisposing factor in the development of breast tuberculosis.
Primary Language | English |
---|---|
Subjects | Health Care Administration |
Journal Section | Original Article |
Authors | |
Publication Date | January 17, 2022 |
Published in Issue | Year 2022 Volume: 5 Issue: 1 |
Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].
The Directories (indexes) and Platforms we are included in are at the bottom of the page.
Note: Our journal is not WOS indexed and therefore is not classified as Q.
You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show
The indexes of the journal are ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.
The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.
Our Journal using the DergiPark system indexed are;
Ulakbim TR Dizin, Index Copernicus, ICI World of Journals, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, OpenAIRE, MIAR, EuroPub, WorldCat (OCLC), DOAJ, Türkiye Citation Index, Türk Medline Index, InfoBase Index
Our Journal using the DergiPark system platforms are;
Journal articles are evaluated as "Double-Blind Peer Review".
Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user. https//dergipark.org.tr/tr/pub/jhsm/page/9535
Journal charge policy https://dergipark.org.tr/tr/pub/jhsm/page/10912
Editor List for 2022
Assoc. Prof. Alpaslan TANOĞLU (MD)
Prof. Aydın ÇİFCİ (MD)
Prof. İbrahim Celalaettin HAZNEDAROĞLU (MD)
Prof. Murat KEKİLLİ (MD)
Prof. Yavuz BEYAZIT (MD)
Prof. Ekrem ÜNAL (MD)
Prof. Ahmet EKEN (MD)
Assoc. Prof. Ercan YUVANÇ (MD)
Assoc. Prof. Bekir UÇAN (MD)
Assoc. Prof. Mehmet Sinan DAL (MD)
Our journal has been indexed in DOAJ as of May 18, 2020.
Our journal has been indexed in TR-Dizin as of March 12, 2021.
Articles published in the Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.